On Ju­ly 26, Al­gimed Techno suc­cess­fully passed the su­per­vis­ory audit ac­cord­ing to the in­ter­n­a­tion­al stand­ard and con­firmed the cer­ti­fic­ates ISO 9001:2015 and ISO 13485:2016.

«Al­gimed Techno» suc­cess­fully and dy­nam­ic­ally de­vel­ops. We have grown from a small labor­at­ory to one of the lead­ing sci­entif­ic and bi­o­tech­no­lo­gic­al man­u­fac­tur­ers in just 4 years. To en­sure an ef­fect­ive in­crease in the pro­duc­tion volume, it is time to modern­ize labor­at­or­ies, ex­pand ad­min­is­trat­ive and pro­duc­tion parts, as well as ware­house.

On June 14, 2023, in Baku, more than 100 spe­ci­al­ists from Azerbai­jan, Tur­key, Croa­tia, Be­larus and Rus­sia took part in a con­fer­ence ded­ic­ated to droplet PCR re­search and its ap­plic­a­tion in sci­ence and dia­gnost­ics. The main goal of the event or­gan­izer Bayramli Group was to em­phas­ize the im­port­ance of de­vel­op­ing mo­lec­u­lar tech­no­lo­gies in Azerbai­jan and Western Asia, as they provide new op­por­tun­it­ies for re­search and dia­gnos­is of in­fec­tions, de­tec­tion of single tu­mor cells, vir­al load assess­ment in food safety and vac­cine pro­duc­tion.

Al­gimed Tech­no – ma­n­u­fac­tu­rer of NOVA­prep® Equip­ment and Re­agents for Li­quid-Based Cyto­logy sup­ports the pre­ven­tion, de­tec­tion and treat­ment of cer­vic­al can­cer. “ No wo­man should die from a pre­vent­able disease. Elim­in­a­tion of cer­vic­al can­cer is with­in our grasp if we unite be­hind this com­mon goal and de­liv­er vac­cin­a­tion, screen­ing and treat­ment. ” Dr Nino Berdzuli, Dir­ect­or of Coun­try Health Pro­grammes, WHO Re­gion­al Of­fice for Europe.

We are glad to present our own product – Deep Well Plate (96 wells)! The Deep Well Plate is re­com­men­ded for use when high chem­ic­al res­ist­ance, re­duced sample bind­ing, cent­ri­fu­ga­tion, long term st­or­age or use at ex­treme tem­per­at­ures are re­quired.

On June 2, 2022 Al­gimed Techno suc­cess­fully passed the re­gis­tra­tion and re­ceived the cer­ti­fic­ate of con­form­ity for Ig­GRBD-SARS-CoV-2 ELISA kit. The kit have been gran­ted CE-IVD status, ac­cord­ing to Dir­ect­ive 98/79/EC of the European Par­lia­ment on the treat­ment of med­ic­al products, thereby con­firm­ing com­pli­ance with all European Uni­on acts and stand­ards, its qu­al­ity and safety for health.

NOVAprep® is a com­pre­hens­ive solu­tion for dia­gnos­ing on­co­lo­gic­al diseases of vari­ous loc­al­iz­a­tions and screen­ing wo­men for cer­vic­al can­cer. NOVAprep® has been gran­ted CE-IVD status un­der Dir­ect­ive 98/79/EC of the European Par­lia­ment on in vitro dia­gnost­ic med­ic­al devices, which con­firms the safety of NOVAprep® med­ic­al products and equip­ment and com­pli­ance with European Uni­on qu­al­ity stand­ards.